Proposed Rule - Adverse Drug Experience Reporting Requirements For Marketed Prescription Drugs Without Approved New Drug Or Abbreviated New Drug Applications

OMB 0910-0210

OMB 0910-0210

© 2021 OMB.report | Privacy Policy